Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verastem, Inc.(VSTM) | 2,732,079 | 3,302,300 | +570,221 | $21.09M | $17.50M | 15.39% | -$3.59M |
| Tenax Therapeutics, Inc.(TENX) | 11,884 | 975,200 | +963,316 | $144.9K | $15.59M | 13.72% | +$15.45M |
| Evolus, Inc.(EOLS) | 1,631,588 | 1,759,091 | +127,503 | $10.85M | $7.23M | 6.36% | -$3.62M |
| Adma Biologics Inc | 740,000 | 740,000 | 0 | $13.50M | $6.67M | 5.86% | -$6.83M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 228,894 | 1,389,622 | +1,160,728 | $1.40M | $6.13M | 5.39% | +$4.73M |
| Nektar Therapeutics(NKTR) | 85,000 | 85,000 | 0 | $3.59M | $6.12M | 5.38% | +$2.52M |
| Zevra Therapeutics, Inc.(ZVRA) | 569,088 | 480,000 | -89,088 | $5.10M | $4.47M | 3.93% | -$625.4K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 389,916 | 383,462 | -6,454 | $3.17M | $3.60M | 3.17% | +$426.8K |
| Abeona Therapeutics Inc.(ABEO) | 709,505 | 746,587 | +37,082 | $3.74M | $3.34M | 2.94% | -$394.4K |
| Kazia Therapeutics LimitedADS(KZIA) | 460,359 | 345,179 | -115,180 | $3.17M | $2.57M | 2.26% | -$603.7K |
| An2 Therapeutics Inc | 627,668 | 713,845 | +86,177 | $715.5K | $2.44M | 2.15% | +$1.73M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 0 | 27,778 | +27,778 | $0 | $2.20M | 1.94% | +$2.20M |
| Xoma Royalty Corporation | 115,000 | 69,500 | -45,500 | $3.06M | $2.18M | 1.92% | -$877.6K |
| Aytu Biopharma Inc | 813,704 | 792,289 | -21,415 | $2.12M | $2.16M | 1.90% | +$47.3K |
| Curis, Inc.(CRIS) | 59,349 | 3,726,406 | +3,667,057 | $58.6K | $2.04M | 1.79% | +$1.98M |
| TELA Bio, Inc.(TELA) | 2,352,032 | 2,617,252 | +265,220 | $2.78M | $1.62M | 1.43% | -$1.15M |
| Inhibikase Therapeutics, Inc.(IKT) | 2,348,147 | 957,202 | -1,390,945 | $4.81M | $1.61M | 1.41% | -$3.21M |
| Crescent Biopharma, Inc.(CBIO) | 87,682 | 85,000 | -2,682 | $1.04M | $1.56M | 1.37% | +$521.5K |
| Adicet Bio Inc | 220,011 | 221,955 | +1,944 | $1.85M | $1.51M | 1.33% | -$341.0K |
| X4 Pharmaceuticals, Inc.(XFOR) | 593,573 | 335,309 | -258,264 | $2.37M | $1.38M | 1.22% | -$989.5K |
| OKYO Pharma LimitedSHS NEW(OKYO) | 0 | 850,000 | +850,000 | $0 | $1.37M | 1.20% | +$1.37M |
| Heron Therapeutics, Inc.(HRTX) | 1,237,802 | 1,402,191 | +164,389 | $1.61M | $1.12M | 0.99% | -$487.3K |
| Pulmonx Corporation(LUNG) | 486,400 | 768,288 | +281,888 | $1.07M | $991.1K | 0.87% | -$83.9K |
| In8bio Inc | 164,893 | 663,412 | +498,519 | $385.9K | $981.9K | 0.86% | +$596.0K |
| Surrozen, Inc.(SRZN) | 113,631 | 33,005 | -80,626 | $2.57M | $961.4K | 0.85% | -$1.61M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 200,000 | +200,000 | $0 | $940.0K | 0.83% | +$940.0K |
| PMV Pharmaceuticals, Inc.(PMVP) | 1,150,759 | 708,102 | -442,657 | $1.44M | $878.0K | 0.77% | -$560.4K |
| BioAge Labs, Inc.(BIOA) | 45,000 | 50,000 | +5,000 | $595.4K | $874.5K | 0.77% | +$279.1K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 0 | 310,000 | +310,000 | $0 | $812.2K | 0.71% | +$812.2K |
| Radiopharm Theranostics LimitedADS(RADX) | 51,000,000 | 51,000,000 | 0 | $850.9K | $739.0K | 0.65% | -$111.9K |
| MaxCyte, Inc.(MXCT) | 469,018 | 1,004,673 | +535,655 | $727.0K | $705.8K | 0.62% | -$21.2K |
| Codexis, Inc.(CDXS) | 256,106 | 417,994 | +161,888 | $417.5K | $681.3K | 0.60% | +$263.9K |
| Boundless Bio, Inc.(BOLD) | 710,071 | 597,682 | -112,389 | $852.1K | $657.5K | 0.58% | -$194.6K |
| Cybin D/B/A Helus Pharma(HELP) | 339,902 | 134,060 | -205,842 | $2.78M | $643.5K | 0.57% | -$2.14M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 463,700 | 269,100 | -194,600 | $626.0K | $629.7K | 0.55% | +$3.7K |
| Pasithea Therapeutics Corp.(KTTA) | 275,062 | 831,301 | +556,239 | $354.8K | $616.7K | 0.54% | +$261.8K |
| Satellos Bioscience Inc.(MSLE) | 0 | 100,000 | +100,000 | $0 | $563.0K | 0.50% | +$563.0K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 50,010 | +50,010 | $0 | $555.6K | 0.49% | +$555.6K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 132,578 | +132,578 | $0 | $548.9K | 0.48% | +$548.9K |
| Xilio Therapeutics, Inc.(XLO) | 0 | 64,162 | +64,162 | $0 | $539.6K | 0.47% | +$539.6K |
| Verrica Pharmaceuticals Inc.(VRCA) | 353,669 | 99,735 | -253,934 | $2.94M | $527.6K | 0.46% | -$2.41M |
| Candel Therapeutics, Inc.(CADL) | 0 | 102,500 | +102,500 | $0 | $502.3K | 0.44% | +$502.3K |
| Precision Optics Corporation, Inc.(POCI) | 0 | 100,000 | +100,000 | $0 | $439.0K | 0.39% | +$439.0K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 78,189 | 53,460 | -24,729 | $1.13M | $352.8K | 0.31% | -$775.4K |
| Establishment Labs Holdings Inc.(ESTA) | 0 | 6,000 | +6,000 | $0 | $340.7K | 0.30% | +$340.7K |
| Upstream Bio, Inc.(UPB) | 0 | 35,000 | +35,000 | $0 | $315.0K | 0.28% | +$315.0K |
| Opus Genetics, Inc.(IRD) | 0 | 68,688 | +68,688 | $0 | $312.5K | 0.27% | +$312.5K |
| Arvinas, Inc.(ARVN) | 0 | 27,500 | +27,500 | $0 | $291.5K | 0.26% | +$291.5K |
| Pliant Therapeutics, Inc.(PLRX) | 230,050 | 224,650 | -5,400 | $280.7K | $283.1K | 0.25% | +$2.4K |
| Janux Therapeutics, Inc.(JANX) | 20,000 | 20,000 | 0 | $276.0K | $278.0K | 0.24% | +$2.0K |
| OmniAb, Inc.(OABI) | 701,000 | 164,045 | -536,955 | $1.30M | $257.6K | 0.23% | -$1.04M |
| Xeris Biopharma Holdings Inc | 0 | 40,030 | +40,030 | $0 | $232.2K | 0.20% | +$232.2K |
| Compugen Ltd.(CGEN) | 305,400 | 104,300 | -201,100 | $467.3K | $222.2K | 0.20% | -$245.1K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 100,000 | +100,000 | $0 | $195.0K | 0.17% | +$195.0K |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 50,000 | +50,000 | $0 | $191.5K | 0.17% | +$191.5K |
| SI-BONE, Inc.(SIBN) | 0 | 14,964 | +14,964 | $0 | $189.0K | 0.17% | +$189.0K |
| Edesa Biotech, Inc.(EDSA) | 687,500 | 30,000 | -657,500 | $976.3K | $156.9K | 0.14% | -$819.4K |
| CNS Pharmaceuticals, Inc.(CNSP) | 48,827 | 61,000 | +12,173 | $256.3K | $145.8K | 0.13% | -$110.6K |
| Processa Pharmaceuticals, Inc.(PCSA) | 12,323 | 55,000 | +42,677 | $35.5K | $138.9K | 0.12% | +$103.4K |
| Cabaletta Bio, Inc.(CABA) | 171,100 | 50,000 | -121,100 | $374.7K | $134.5K | 0.12% | -$240.2K |
| Kalaris Therapeutics, Inc.(KLRS) | 0 | 20,400 | +20,400 | $0 | $117.7K | 0.10% | +$117.7K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 893,100 | 35,000 | -858,100 | $1.35M | $107.8K | 0.09% | -$1.24M |
| Ovid Therapeutics Inc.(OVID) | 102,367 | 40,000 | -62,367 | $166.9K | $88.8K | 0.08% | -$78.1K |
| Evaxion A/SADS(EVAX) | 20,000 | 19,713 | -287 | $95.4K | $73.3K | 0.06% | -$22.1K |
| MannKind Corporation(MNKD) | 86,359 | 16,300 | -70,059 | $489.7K | $39.9K | 0.04% | -$449.7K |
| BioAtla, Inc.(BCAB) | 0 | 65,387 | +65,387 | $0 | $10.5K | 0.01% | +$10.5K |
| Acadia Pharmaceuticals Inc | 100,000 | 0 | -100,000 | $2.67M | $0 | — | -$2.67M |
| Day One Biopharmaceuticals I COM | 200,000 | 0 | -200,000 | $1.86M | $0 | — | -$1.86M |
| Delcath Systems, Inc.(DCTH) | 27,232 | 0 | -27,232 | $275.0K | $0 | — | -$275.0K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 100,000 | 0 | -100,000 | $1.58M | $0 | — | -$1.58M |
| Fennec Pharmaceuticals Inc.(FENC) | 50,000 | 0 | -50,000 | $385.0K | $0 | — | -$385.0K |
| Geron Corporation(GERN) | 805,800 | 0 | -805,800 | $1.06M | $0 | — | -$1.06M |
| Gossamer Bio, Inc.(GOSS) | 204,770 | 0 | -204,770 | $634.8K | $0 | — | -$634.8K |
| Indivior Plc | 100,000 | 0 | -100,000 | $3.59M | $0 | — | -$3.59M |
| Kezar Life Sciences Inc COM NEW | 156,179 | 0 | -156,179 | $982.4K | $0 | — | -$982.4K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 131,144 | 0 | -131,144 | $258.4K | $0 | — | -$258.4K |
| Milestone Pharmaceuticals Inc.(MIST) | 662,666 | 0 | -662,666 | $1.34M | $0 | — | -$1.34M |
| Semler Scientific Inc | 50,000 | 0 | -50,000 | $764.5K | $0 | — | -$764.5K |
| Spruce Biosciences Inc | 19,742 | 0 | -19,742 | $1.72M | $0 | — | -$1.72M |
| Tenaya Therapeutics, Inc.(TNYA) | 352,001 | 0 | -352,001 | $250.4K | $0 | — | -$250.4K |
| Xilio Therapeutics, Inc.(XLO) | 126,270 | 0 | -126,270 | $80.8K | $0 | — | -$80.8K |